19 research outputs found

    The Process of Replication Target Selection in Psychology: What to Consider?

    Get PDF
    Increased execution of replication studies contributes to the effort to restore credibility of empirical research. However, a second generation of problems arises: the number of potential replication targets is at a serious mismatch with available resources. Given limited resources, replication target selection should be well justified, systematic, and transparently communicated. At present the discussion on what to consider when selecting a replication target is limited to theoretical discussion, self-reported justifications, and a few formalized suggestions. In this Registered Report, we proposed a study involving the scientific community to create a list of considerations for consultation when selecting a replication target in psychology. We employed a modified Delphi approach. First, we constructed a preliminary list of considerations. Second, we surveyed psychologists who previously selected a replication target with regards to their considerations. Third, we incorporated the results into the preliminary list of considerations and sent the updated list to a group of individuals knowledgeable about concerns regarding replication target selection. Over the course of several rounds, we established consensus regarding what to consider when selecting a replication target

    The process of replication target selection in psychology: what to consider?

    Get PDF
    Increased execution of replication studies contributes to the effort to restore credibility of empirical research. However, a second generation of problems arises: the number of potential replication targets is at a serious mismatch with available resources. Given limited resources, replication target selection should be well-justified, systematic and transparently communicated. At present the discussion on what to consider when selecting a replication target is limited to theoretical discussion, self-reported justifications and a few formalized suggestions. In this Registered Report, we proposed a study involving the scientific community to create a list of considerations for consultation when selecting a replication target in psychology. We employed a modified Delphi approach. First, we constructed a preliminary list of considerations. Second, we surveyed psychologists who previously selected a replication target with regards to their considerations. Third, we incorporated the results into the preliminary list of considerations and sent the updated list to a group of individuals knowledgeable about concerns regarding replication target selection. Over the course of several rounds, we established consensus regarding what to consider when selecting a replication target. The resulting checklist can be used for transparently communicating the rationale for selecting studies for replication

    Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?

    No full text
    Background. In patients with hepatitis C virus (HCV) infection, the activation of theimmune system by the virus or viral proteins leads to the production of numerous autoantibodiesand clinical manifestations. The objectives of this study were to investigate therelationship between HCV and anti-HLA antibodies, as well as the effect of viremia on theantibody response and of direct-acting antivirals (DAAs) on anti-HLA antibodypersistence in patients on the waiting list for a cadaveric kidney transplant.Methods. A total of 395 patients from the cadaveric renal transplant waiting list wereincluded in the study. The patients were grouped according to the presence of HCVinfection, and patients with HCV positivity were further divided into a spontaneousclearance group and a persistent group. Anti-HLA antibodies were examined before andafter treatment of the patients in the persistent group. The One Lambda Luminexmethod (Thermo Fisher Scientific, Waltham, MA, United States) was used to assessboth HLA class I and II alleles and the anti-HLA antibody profile.Results. Anti-HLA class I and II antibodies were detected in 48.2% and 55.1%,respectively, of the patients infected with HCV and in 21.8% and 20.4%, respectively, ofthe patients who were not infected. The level of anti-HLA A3, A11, B72, B52, Cw6, Cw16,DR3, and DQ4 antibodies was significantly higher in the patients infected with HCV.There was no statistically significant difference in class I and II antibody titrationbetween the HCV-infected spontaneous clearance group and the persistent group (classI mean fluorescence intensity [MFI] SD: 13,583 6224, 13,450 9540, P ÂĽ .808;Class II MFI SD: 13,000 8673, 8440 8302, P ÂĽ .317, respectively). There was nosignificant difference in the class I and class II anti-HLA antibody profile and titrationin the persistent group after treatment with DAAs (P > .05).Conclusions. The results of this study demonstrated that hepatitis C DAA treatment didnot change the anti-HLA antibody profile and titration

    Infectious Complications of Induction Therapies in Kidney Transplantation.

    No full text
    Background: Cytomegalovirus (CMV) and BK virus (BKV) are post-transplant opportunistic viral infections that affect patientand graft survival. This study was designed to evaluate the risk of BKV nephropathy and CMV disease in kidneytransplant recipients who received induction therapy with ATG or basiliximab.Material/Methods: We retrospectively analyzed information on 257 adult patients who underwent kidney transplantation betweenJanuary 2007 and 2017. Patients were categorized into 3 groups according to the induction therapies. The primaryendpoint was the onset of CMV disease or biopsy-confirmed BKV nephropathy. The secondary endpointswere biopsy-proven rejection episodes, graft loss, loss to follow-up, and death.Results: We followed 257 patients for a median of 55.5 months. The incidence of CMV disease was significantly higherin the only ATG group compared to the group without induction treatment (p<0.001). There was no significantdifference in the incidence of BKV nephropathy among groups (p>0.05). The dosage of ATG (OR, 10.685; 95%CI, 1.343 5 to 85.009; P=0.025) was independent risk factor for death.Conclusions: This study demonstrated that a higher dosage of ATG in high-risk patients is associated with an increased riskof CMV disease and patient death, also, reducing the dosage may be a rational strategy for increasing graftand patient’s survival

    The process of replication target selection in psychology: what to consider?

    No full text
    From The Royal Society via Jisc Publications RouterHistory: received 2021-04-07, accepted 2023-01-13, collection 2023-02, pub-electronic 2023-02-01Peer reviewed: TrueArticle version: VoRPublication status: PublishedFunder: NWOIncreased execution of replication studies contributes to the effort to restore credibility of empirical research. However, a second generation of problems arises: the number of potential replication targets is at a serious mismatch with available resources. Given limited resources, replication target selection should be well-justified, systematic and transparently communicated. At present the discussion on what to consider when selecting a replication target is limited to theoretical discussion, self-reported justifications and a few formalized suggestions. In this Registered Report, we proposed a study involving the scientific community to create a list of considerations for consultation when selecting a replication target in psychology. We employed a modified Delphi approach. First, we constructed a preliminary list of considerations. Second, we surveyed psychologists who previously selected a replication target with regards to their considerations. Third, we incorporated the results into the preliminary list of considerations and sent the updated list to a group of individuals knowledgeable about concerns regarding replication target selection. Over the course of several rounds, we established consensus regarding what to consider when selecting a replication target. The resulting checklist can be used for transparently communicating the rationale for selecting studies for replication

    The process of replication target selection in psychology: what to consider?

    No full text
    From Europe PMC via Jisc Publications RouterHistory: epub 2023-02-01, ppub 2023-02-01Publication status: PublishedIncreased execution of replication studies contributes to the effort to restore credibility of empirical research. However, a second generation of problems arises: the number of potential replication targets is at a serious mismatch with available resources. Given limited resources, replication target selection should be well-justified, systematic and transparently communicated. At present the discussion on what to consider when selecting a replication target is limited to theoretical discussion, self-reported justifications and a few formalized suggestions. In this Registered Report, we proposed a study involving the scientific community to create a list of considerations for consultation when selecting a replication target in psychology. We employed a modified Delphi approach. First, we constructed a preliminary list of considerations. Second, we surveyed psychologists who previously selected a replication target with regards to their considerations. Third, we incorporated the results into the preliminary list of considerations and sent the updated list to a group of individuals knowledgeable about concerns regarding replication target selection. Over the course of several rounds, we established consensus regarding what to consider when selecting a replication target. The resulting checklist can be used for transparently communicating the rationale for selecting studies for replication
    corecore